PharmiNews

The Directory of Pharma Companies and News

Otsuka

Category:
Category:

Otsuka News

DateNews
2017-01-06Otsuka Submits New Drug Application in Japan for Brexpiprazole in the Treatment of Schizophrenia
2016-12-20JSC High Performance Center Total Conditioning Research ProjectJoint research aims to promote sports medicine and scienc...
2016-12-01FDA Accepts For Review A Supplemental New Drug Application To Expand Labeling Of Abilify Maintena® (aripiprazole) For Th...
2016-11-25Otsuka Joins UN Global Compact
2016-11-24Otsuka Pharmaceutical Enters into Cooperative Agreements with Hokkaido Government Entities- Partnership Agreement for Pr...
2016-11-11Notice Concerning Voluntary Adoption ofInternational Financial Reporting Standards (IFRS)
2016-11-11Otsuka Holdings announces 3Q FY2016 financial results.
2016-08-09Otsuka Holdings announces 2Q FY2016 financial results.
2016-08-05Notice Regarding Completion of Share Transfer of an Affiliated Company Accounted for by the Equity Method
2016-07-29Notice concerning amendments to the forecasts for the first half of FY2016
2016-06-01Determination of Final Terms of Share Remuneration-type Stock Options (Share Acquisition Rights)
2016-05-31Otsuka Holdings Announces New, Additional Certification Under “ISO 22301”, the International Standard for Business Conti...
2016-05-17Notification of Change of Equity Method Affiliate (Transfer of Shares)
2016-05-16Otsuka Holdings Announces Collaboration with ReCor Medical for Commercialization of ReCor Medical’s Ultrasound Renal Den...
2016-05-13Issuance of Share Remuneration-type Stock Options (Share Acquisition Rights)
2016-05-13Otsuka Holdings announces 1Q FY2016 financial results.
2016-03-30Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members
2016-02-12Introduction of Share Remuneration-type Stock Options (Share Acquisition Rights)
2016-02-12Otsuka Holdings announces FY2015 financial results.
2015-12-07Otsuka Files for Approval in Japan for an Additional Indication for the Antipsychotic ABILIFY: Excitability Associated w...
2015-08-07Otsuka Holdings announces 2Q FY2015 financial results.
2015-07-30Notice concerning amendments to the forecasts for the first half of FY2015
2015-07-11U.S. FDA APPROVES OTSUKA AND LUNDBECK’S REXULTI® (BREXPIPRAZOLE) AS ADJUNCTIVE TREATMENT FOR ADULTS WITH MAJOR DEPRESSIV...
2015-05-13Otsuka Holdings announces 1Q FY2015 financial results.
2015-04-30Otsuka announces 2015 first quarter U.S. net sales figures of ABILIFY®
2015-03-27Otsuka Holdings Announces Change in Status of Representative Director
2015-03-26Otsuka Granted Approval in Japan for a New Formulation of ABIILIFY – ABILIFY for Extended–release Injectable Suspension,...
2015-02-27Otsuka Pharmaceutical Receives Princess Chichibu Memorial Award for Distinguished Service to Tuberculosis Elimination
2015-02-26TAKECAB® Now Available for the Treatment of Acid-related Diseases in Japan
2015-02-13Otsuka Holdings announces FY2014 financial results.
2015-02-13Otsuka Holdings Announces Personnel Change of Representative Director
2015-02-12Notice of Change of Representative Director of Otsuka Pharmaceutical Co Ltd(Concurrent Obituary?
2015-01-28Otsuka announces 2014 fourth quarter U.S. net sales figures of ABILIFY®
2015-01-13Otsuka Pharmaceutical Completes Acquisition of Avanir Pharmaceuticals
2015-01-08Terminations of Otsuka’s Contract With OncoTherapy Science, Inc. on a Candidate Therapeutic Vaccine For Pancreatic Cance...
2015-01-05Otsuka Holdings Announces Expiration of HSR Waiting Period for Avanir Tender Offer
2014-12-26New Drug Application Approval of TAKECAB® for the treatment of Acid-related Diseases in Japan
2014-12-13Otsuka Pharmaceutical Commences Tender Offer to Acquire All Outstanding Shares of Avanir Pharmaceuticals
2014-12-11OTSUKA AND LUNDBECK’S BREXPIPRAZOLE DEMONSTRATES STATISTICALLY SIGNIFICANT EFFECTS IN NEW PHASE III STUDIES IN ADULT PAT...
2014-12-10OTSUKA AND LUNDBECK PRESENT PHASE III DATA ON BREXPIPRAZOLE AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH MAJOR DEPRESSIO...
2014-12-08U.S. FDA APPROVES THE LABELING UPDATE OF ABILIFY MAINTENA® (ARIPIPRAZOLE) FOR EXTENDED-RELEASE INJECTABLE SUSPENSION TO ...
2014-12-02Otsuka Pharmaceutical to Acquire Avanir PharmaceuticalsFull-scale entry to neurologic diseases area widens core business...
2014-12-01Notice of Change of Representative Director (Obituary)
2014-11-19Otsuka Holdings’ Chairman and Representative Director Akihiko Otsuka receives the “Legion d’honneur” from France
2014-10-27Otsuka announces 2014 third quarter U.S. net sales figures of ABILIFY®
2014-09-24U.S. FDA ACCEPTS OTSUKA AND LUNDBECK’S FILING FOR REVIEW OF BREXPIPRAZOLE FOR THE TREATMENT OF SCHIZOPHRENIA AND AS ADJU...
2014-08-26Otsuka Holdings announces Second Medium-Term Management Plan
2014-07-25Otsuka announces 2014 second quarter U.S. net sales figures of ABILIFY®
2014-07-14OTSUKA AND LUNDBECK SUBMIT NEW DRUG APPLICATION IN THE US FOR BREXPIPRAZOLE FOR THE TREATMENT OF SCHIZOPHRENIA AND AS AD...
2014-05-14Otsuka Holdings Announces Personnel Changes of Representative Director, Directors and Audit & Supervisory Board Members
2014-05-14Notice Regarding Differences between Non-Consolidated Actual Results for the Fiscal Year Ended March 31, 2013 and Fiscal...
2014-05-14Notice Regarding the Partial Amendment of Articles of Incorporation
2014-04-30Otsuka announces 2014 first quarter U.S. net sales figures of ABILIFY®
2014-03-27Otsuka and Takeda Announce a Co-promotion Agreement in Japan of TAK-438 for the Treatment of Acid-related Diseases in th...
2014-03-03INVESTIGATIONAL COMPOUND BREXPIPRAZOLE MET PRIMARY AND SECONDARY STUDY ENDPOINTS IN PHASE III CLINICAL TRIAL IN MAJOR DE...
2014-01-27Otsuka announces 2013 fourth quarter U.S. net sales figures of ABILIFY®
2014-01-24Otsuka and Lundbeck to present new data on brexpiprazole in major depressive disorder (MDD) at European Psychiatry Assoc...
2014-01-15Otsuka Pharmaceutical Submits Marketing Authorization Application in Japan for Abilify Once-Monthly Injectable Form for ...
2013-11-21Otsuka and Lundbeck's Once-Monthly Abilify Maintena® (Aripiprazole) Now Approved in Europe for Maintenance Treatment of ...
2013-11-14Otsuka Foods Announces Personnel Changes
2013-11-13Notice Regarding Change in Business Year
2013-11-13Otsuka Holdings Announces Personnel Changes
2013-10-24Otsuka announces 2013 third quarter U.S. net sales figures of ABILIFY®
2013-10-11Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
2013-10-07Otsuka Holdings Announces Expiration of HSR Waiting Period for Astex Tender Offer
2013-09-14Otsuka Pharmaceutical Commences Tender Offer to Acquire All Outstanding Shares of Astex Pharmaceuticals
2013-09-05Otsuka Pharmaceutical to Acquire Astex Pharmaceuticals
2013-07-29Otsuka Techno Takes an Equity Interest in a Chinese Firm That Manufactures and Markets Plastic Caps for I.V. Solution-re...
2013-07-26Otsuka announces 2013 second quarter U.S. net sales figures of ABILIFY®
2013-06-20Otsuka Medical Devices Loans MicroPort to Support its Acquisition of Wright Medical’s Hips and Knee Implant Business
2013-06-19Otsuka Holdings Announces Completion of Share Repurchase
2013-06-14A New Choice of Therapy for the Treatment of Depression:ABILIFY® Granted Additional Approval as Adjunctive Therapy for t...
2013-06-04Notice regarding Status of Acquisition of Own Shares
2013-05-22Otsuka Pharmaceutical Factory and Fresenius Kabi Japan enter into an exclusive distribution agreement of HES products, i...
2013-05-16Notice of the Result of Share Repurchase through ToSTNeT-3
2013-05-15Notice of Acquisition of Own Shares through ToSTNeT-3
2013-05-14Otsuka Holdings Co., Ltd. to Acquire Own Shares
2013-04-26Otsuka announces 2013 first quarter U.S. net sales figures of ABILIFY®
2013-03-26Lundbeck and Otsuka Further Expand Alliance and Enter Into Collaboration For the Development and Commercialization of Lu...
2013-03-25Otsuka Obtains Marketing Approval in Japan for Onglyza® Tablets to Treat Type 2 Diabetes; Transferred Rights to Kyowa Ha...
2013-03-01FDA Approves Once-Monthly ABILIFY MAINTENA™ (Aripiprazole) for Extended-Release Injectable Suspension for the Treatment ...
2013-01-25Otsuka announces 2012 fourth quarter U.S. net sales figures of ABILIFY®
2012-12-25Otsuka and Lundbeck initiate the regulatory process for aripiprazole (once-monthly) depot formulation in Europe
2012-12-07Establishment of Joint Venture Company (Subsidiary) in India
2012-10-29Otsuka Medical Devices and Pioneer Form an Alliance in the Medical Endoscope Business
2012-10-25Otsuka announces 2012 third quarter U.S. net sales figures of ABILIFY®
2012-09-12Otsuka and Lundbeck Announce U.S. Food and Drug Administration Acknowledges Receipt of Resubmission of New Drug Applicat...
2012-09-03ABILIFY®,The First Antipsychotic Agent in JapanApplying for Adjunctive Treatment in Major Depressive Disorder
2012-07-27OTSUKA RECEIVES COMPLETE RESPONSE LETTER FOR EXTENDED-RELEASE INJECTABLE SUSPENSION OF ARIPIPRAZOLE
2012-07-26Otsuka announces 2012 second quarter U.S. net sales figures of ABILIFY®
2012-07-13Otsuka Holdings Announces Personnel Changes (Resignation) of Representative Director
2012-06-29Otsuka Pharmaceutical and Kyowa Hakko Kirin announce strategic alliance in the fields of diabetes and oncology
2012-05-08Results from a Phase 3 Study of Once-monthly Aripiprazole Intramuscular (IM) Depot Formulation for the Maintenance Treat...
2012-04-27Otsuka announces 2012 first quarter U.S. net sales figures of ABILIFY®
2012-03-13Otsuka America Announces Personnel Changes
2012-01-27Otsuka announces 2011 fourth quarter U.S. net sales figures of ABILIFY®
2012-01-18Antipsychotic Agent ABILIFY® Receives Regulatory Approvals for Additional Indication "Improvement of Manic Symptoms Asso...
2012-01-13Otsuka Pharmaceutical and UCBfocus collaboration in the area of Central Nervous System (CNS) disorders
2011-12-26Otsuka Medical Device Enters Endoscopic Field by Acquiring Stake in Italy’s Era Endoscopy S.r.l., An Innovator in Self-p...
2011-12-14Otsuka Techno to Construct New Factory at Industrial Park in Naruto, Tokushima
2011-12-12Taiho Pharmaceutical Announces Personnel Changes
2011-12-12Otsuka Chemical Announces Personnel Changes
2011-11-28J.O. Pharma Co., Ltd. to construct a new manufacturing facility for prefilled syringes (a syringe with injectable drug s...
2011-11-22NEW DRUG APPLICATION FOR OTSUKA’S ONCE-MONTHLY ARIPIPRAZOLE DEPOT FORMULATION FOR MAINTENANCE TREATMENT OF ADULT PATIENT...
2011-11-11OTSUKA PHARMACEUTICAL CO., LTD. AND H. LUNDBECK A/S Sign Historic Agreement to Deliver Innovative Medicines with Focus o...
2011-10-31Notice concerning amendments to the forecasts for the first half of FY2011
2011-10-28Otsuka announces 2011 third quarter U.S. net sales figures of ABILIFY®
2011-10-19Otsuka Pharmaceutical Factory and Living Cell Technologies Limited Agree to Establish Joint Venture to Develop and Comme...
2011-10-17Otsuka Medical Devices Acquires KiSCO Medical Group,Enters the Field of Orthopedic Surgery
2011-07-29Otsuka announces 2011 second quarter U.S. net sales figures of ABILIFY®
2011-07-21Taiho Pharmaceutical Co., Ltd. and Nordic Group BV Enter into a Development and Commercialization Agreement for the rece...
2011-06-10Otsuka Warehouse Announces Personnel Changes
2011-05-16Otsuka Holdings Formulates First Medium-Term Management Plan
2011-05-16OTSUKA PHARMACEUTICAL CO., LTD. ANNOUNCES RESULTS FROM A PHASE 2 STUDY OF INVESTIGATIONAL PRODUCT OPC-34712 AS ADJUNCTIV...
2011-05-02Otsuka announces 2011 first quarter U.S. net sales figures of ABILIFY®
2011-04-13Announcement of License Agreement on a New Antiemetic Combination Agent (Taiho Pharmaceutical)
2011-04-12OTSUKA PHARMACEUTICAL FACTORY INVESTS IN LIVING CELL TECHNOLOGIES LIMITED,A BIOTECHNOLOGY COMPANY ADVANCING DEVELOPMENT ...
2011-03-31Notice Regarding Effects of the Tohoku Pacific Offshore Earthquake (3)
2011-03-28EN Otsuka Pharmaceutical Announces Changes to Board Members
2011-03-25Announcement of Promotion of Managing Director (Taiho Pharmaceutical)
2011-03-22Notice Regarding Support in Response to the Tohoku Pacific Offshore Earthquake
2011-03-16Notice Regarding Effects of the Tohoku Pacific Offshore Earthquake (2)
2011-03-15TEYSUNO™ (S-1) RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR ADVANCED GASTRIC CANCER
2011-03-14Notice Regarding Effects of the Tohoku Pacific Offshore Earthquake
2011-03-07Otsuka Pharmaceutical Announces Changes to Board Members
2011-03-03Day Care Center for ChildrenBeanStalk Kids Center TOKUSHIMAOpening April 1, 2011
2011-02-18ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valp...
2011-02-16Otsuka Foods and Otsuka Pharmaceutical to Partner with ITO EN on Cross-Sales of Products in Vending Machines
2011-02-14Otsuka Holdings Announces Establishment of a Subsidiary and Company Splits (Short-Form Absorption-Type Splits) to Reorga...
2011-02-14Financial Results for 3Q/FY2010
2011-02-03Otsuka Holdings Co., Ltd. Obtains Credit Rating
2011-02-01Otsuka Announces Initiation of Phase II Clinical Trials for Angiogenesis Inhibitor OCV-101
2011-01-31Nutraceutical Business in Europe Moves to New Stage SOYJOY, the First Japanese Product, Set to Debut in 4 Countries
2011-01-28Otsuka announces 2010 U.S. net sales figures of ABIFILY®
2011-01-24Otsuka Pharmaceutical Files for Additional Indication Regulatory Approval in Japan for ABILIFY®, a Treatment for the Man...
2010-12-27Notice Concerning Loan Transaction Stocks Assignment
2010-12-16Defendants Appeal From Final Judgment in U.S. Abilify® Patent Litigation
2010-12-15Otsuka Holdings listed on the First Section of the Tokyo Stock Exchange
2010-12-15Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2011 [Japan GAAP]
2010-11-16Otsuka Prevails in U.S. Abilify® Patent Litigation
2010-06-29Otsuka Holdings Co., Ltd. Appoints the Board Members and Statutory Auditors
2010-05-14Fiscal Year through March 2010 – Consolidated Results
2009-11-13Otsuka Holdings announces “Research and Development” website opens on November 13, 2009
2009-10-09Otsuka Holdings receives the 2009 Investor in France Award on October 8, 2009
2009-05-15Fiscal Year through March 2009 – Consolidated Results
2009-05-08Announcement regarding the conversion of Otsuka Chemical Holdings into a wholly owned subsidiary of Otsuka Holdings
2008-12-24Otsuka Pharmaceutical Co., Ltd. to acquire Nutrition & Santé, the European market leader in functional and dietetic food...
2008-08-20Otsuka Holdings Co., Ltd. Appoints the Board Members
2008-07-25Notice of the Reorganization of Three Otsuka Group Companies(Otsuka Pharmaceutical Factory, Otsuka Warehouse, and Taiho ...
2008-07-08Tatsuo Higuchi Appointed as President, Representative Director of Otsuka Holdings Co., Ltd.
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.